Elucidating the role of Lrrc34 in the regulation of ribosome biogenesis and Oct4 in mouse and human pluripotent stem cells
Elucidating the role of Lrrc34 in the regulation of ribosome biogenesis and Oct4 in mouse and human pluripotent stem cells
批准号:
323786205
负责人:
Dr. Jessica Nolte
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31
中文摘要
在本基金的框架下,分析Lrrc 34基因在多能干细胞核仁中的功能将是研究的重点,目前对该基因的了解还不多,它只在干细胞和雄性生殖细胞中表达,其蛋白主要位于核仁中.结果表明,Lrrc34的表达调控导致胚胎干细胞的差异生长和多能性基因(如Oct4)的表达改变,由于核仁是核糖体生物发生的场所,因此Lrrc34在核糖体生物发生中的作用将被研究。此外,还将进一步分析Oct4的调控及其相互作用。为此,将使用体外试验(小鼠和人)以及基因敲除小鼠模型的生成和表征。
英文摘要
In the frame of the presented grant it will be the focus to analyze thefunction of the gene Lrrc34 in the nucleolus of pluripotent stem cells.Up till know there is not much known about the gene: it is exclusivelyexpressed in stem cells and male germ cells and its protein ispredominantly located in the nucleolus. It is shown, that regulation ofLrrc34 expression resulted in differentially growing of embryonic stemcells and an altered expression of pluripotency genes (e.g. Oct4).Since the nucleolus is the place of ribosome biogenesis,the role of Lrrc34 in ribosome biogenesis will beinvestigated. Furthermore the regulation of and interaction with Oct4 will be further analysed. For this, in vitro assays (mouse and human) as well as the generation and characterization of a knock-out mouse model will be used.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Lrrc34 interacts with Oct4 and has an impact on telomere length in mouse Embryonic Stem Cells.
Lrrc34 与 Oct4 相互作用并对小鼠胚胎干细胞中的端粒长度产生影响
DOI:
10.1089/scd.2021.0113
发表时间:
2021
期刊:
Stem cells and development
影响因子:
4
作者:
[]
通讯作者:
Zum Potential spermatogonialer Stammzellen
-
批准号:71042814
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Dr. Jessica Nolte
-
依托单位:
Characterization of putative pluripotency-regulating genes and defining the role of germ cell-specific genes during reprogramming
-
批准号:66168673
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Dr. Jessica Nolte
-
依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位: